Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 11, 2003 - Issue 1
Submit an article Journal homepage
27
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Peripapillary choroidal atrophy in sympathetic ophthalmia and management with triple-agent immunosuppression

Sudha K. Ganesh Uvea Service, Sankara Nethralaya, Medical Research Foundation, Chennai, India
,
Kannan M. Narayana Uvea Service, Sankara Nethralaya, Medical Research Foundation, Chennai, India
&
Jyotirmay Biswas Uvea Service, Sankara Nethralaya, Medical Research Foundation, Chennai, India
Pages 61-65 | Published online: 08 Jul 2009

References

  • Chee SP, Yeo YSI. Peripapillary atrophy in Vogt-Koyanagi-Harada syndrome. In: Ohno S, Aoki K, Usui M, Uchio E, editors. Uveitis today. Amsterdam: Elsevier Science, 1998; 181–184.
  • Rao NA, Forster DJ, Augsburger H. The uvea — uveitis and intraocular neoplasms. In: Podos SM, Yanoff M, editors. Textbook of ophthalmology, Vol. II. New York: Gower Medical Publishing, 1992;8.13-8.17 (Vogt-Koyanagi-Harada syndrome).
  • Ramadan A, Nussenblatt RB. Visual prognosis and sympathetic ophthalmia. Curr Opin Ophthalmol. 1996;7:39–45.
  • Dada T, Kumar A, Sharma N. Sympathetic ophthalmia associated with antecedent adherent leucoma: a rare association. Acta Ophthalmol Scand. I 998 ;76(3):380–38r.
  • Gass JD. Sympathetic ophthalmia following vitrectomy. Am J Ophthalmol. 1982;93:552–558.
  • Hebestreit H, Huppertz HI, Sold JE, Dammrich J. Steroid-pulse therapy may suppress inflammation in severe sympathetic ophthalmia. J Pediatr Ophthalmol Strabismus. 1997;34(2):124–126.
  • Nussenblatt RB, Palestine A, Chan CC. Cyclosporine therapy for uveitis: long term follow-up. J Ocul Pharmacol. I 985; I :369–382.
  • Philip L, Hooper PL, Kaplan HJ, MD. Triple agent immunosuppression in serpiginous choroiditis. Ophthalmology. 1991; 98(6):944–952.
  • Tessler HH, Jennings T. High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behget's disease. Br J Ophthalmol. 1990;74:353–357.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.